Part 7/10:
Global Spread: Bacteria can traverse borders effortlessly, thanks to international travel and trade, accelerating the dissemination of resistant infections.
Lack of New Antibiotics: The pace of antibiotic development has stagnated, with the last new class created decades ago. Pharmaceutical companies face disincentives to invest in new antibiotics due to limited financial returns.
Risks to Routine Medical Procedures: Antibiotics are critical for preventing infections during surgeries, organ transplants, and cancer treatments. The absence of effective antibiotics makes these procedures significantly more hazardous.